Collection of Circulating Biomarkers in Pancreatic Cancer

This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.

Inclusion Criteria:The subject must have a known or presumed diagnosis of pancreatic adenocarcinomaThe subject must be a patient of the University of PennsylvaniaThe subject must be able to provide informed consentThe subject must be 18 years of age or olderExclusion Criteria:. Subjects who have any clinically significant psychiatric, social, or medical condition that, in the opinion of the investigator, could increase the patient's risk, interfere with protocol adherence, or affect the patient's ability to give informed consent are ineligible to participate in the study.